Concord Drugs Ltd. (CONCORD)
Market Closed
16 Oct, 10:00 PM
MSE MSE Primary ₹
68. 40
-3.29
-4.5892%
₹
313.46M Market Cap
- P/E Ratio
- Div Yield
4,885 Volume
- Eps
₹ 71.69
Previous Close Want to track CONCORD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Concord Drugs Ltd. (CONCORD) Statistics
Valuation metrics
Market Cap 313.46M
Enterprise value 781.81M
Trailing P/E (ttm) 42.16
Forward P/E -
PEG ratio 0.15
Price/Sales (ttm) 0.91
Price/Book (mrq) 1.9
Enterprise Value/Revenue 0.91
Enterprise Value/EBITDA 13.43
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 5.74K
Average volume (90 days) 6.11K
Price summary
52-Week low 61
52-Week high 92.52
Beta -
50-Day moving average 77.57
200-Day moving average 77
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.02%
Operating margin 0.06%
Operational effectiveness
Return on assets 0.01%
Return on equity 0.05%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 65.67
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.57
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.7
Total debt (mrq) -
Total Debt/Equity (mrq) 0.28
Current ratio (mrq) 2.53%
Book value per share (mrq) 37.02
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
